Conference
HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1 trial
Authors
Hotte SJ; Hirte HW; Chen EX; Le LH; Corey A; Maclean M; Iacobucci A; Fox NL; Oza AM
Volume
23
Pagination
pp. 3052-3052
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 2005
DOI
10.1200/jco.2005.23.16_suppl.3052
Conference proceedings
Journal of Clinical Oncology
Issue
16_suppl
ISSN
0732-183X